UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) November 16, 2026

 

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

(Exact name of registrant as specified in its charter)

 

Cayman Islands   001-42451   N/A
(State or other jurisdiction of
incorporation or organization)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

52 E. 83rd Street,

New York, New York

  10028
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (917) 979-3072

 

Not Applicable

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

x Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading
Symbol(s)
Name of each exchange
on which registered
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant TDACU The Nasdaq Stock Market LLC
Class A ordinary shares, $0.0001 par value per share TDAC The Nasdaq Stock Market LLC
Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 TDACW The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

First Amendment to Agreement and Plan of Merger

 

On November 16, 2026, Translational Development Acquisition Corp., a Cayman Islands exempted company with limited liability (“TDAC”), Prologium Holding Inc., a Cayman Islands exempted company with limited liability (“ProLogium”), and PLG Merger Sub 1 and PLG Merger Sub 2, each a Cayman Islands exempted company with limited liability and a wholly-owned direct subsidiary of ProLogium, entered into the First Amendment to Agreement and Plan of Merger (the “Amendment”). The Amendment amends the Agreement and Plan of Merger, dated as of May 27, 2026, among those parties (as amended, the “Business Combination Agreement”), relating to their previously announced business combination (the “Business Combination”). The material terms of the Amendment are summarized below.

 

Equity Value and Consolidation Factor

 

The Amendment defines “Equity Value” as $3.9 billion, consisting of an enterprise value of $3.8 billion plus agreed net cash of $100 million. Solely for purposes of determining the per-share equity value and the consolidation factor applicable to ProLogium’s recapitalization (the “Consolidation Factor”), the Amendment fixes “Aggregate Company Shares” at 93,682,924, comprising (i) 89,441,230 issued and outstanding pre-recapitalization shares, consisting of 21,836,200 common shares and 67,605,030 preferred shares, (ii) 2,581,694 common shares underlying the outstanding warrants designated as Warrant C and Warrant E+, and (iii) 1,660,000 common shares reserved under ProLogium’s equity incentive plan, including shares underlying granted options and shares approved or reserved for future grants. The warrant and equity incentive plan shares are counted on an as-exercised or reserved basis, whether or not the applicable warrants or options have been exercised or the options have been granted.

 

The Consolidation Factor is 4.16, subject to adjustment for specified changes in ProLogium’s share capital before closing, other than the recapitalization itself. No adjustment will be made solely because of warrant or option exercises, or issuances of options or shares from the equity incentive plan reserve, to the extent already reflected in Aggregate Company Shares. The Amendment also replaces the illustrative calculation in Section 2.01 of the Company Disclosure Schedule with the calculation attached as Annex B to the Amendment.

 

Recapitalization of ProLogium Share Capital

 

The Amendment replaces the share consolidation mechanics with a share exchange to occur on the closing date immediately before the first merger becomes effective. ProLogium will first create the additional authorized shares specified in its revised form of amended and restated memorandum and articles of association (the “Listing Articles”). Each issued and outstanding pre-recapitalization ProLogium share will then be repurchased and cancelled in exchange for the issuance of a number of Class A, Class B or Class C ordinary shares of ProLogium, each with a par value of $0.0001 per share, equal to the Consolidation Factor. Shares held by the Founder Parties (as defined in the Business Combination Agreement) will be exchanged for Class B ordinary shares; shares held by SBCVC FUND IV, L.P. (the “SBCVC Shareholder”), New Epoch Capital LP (“New Epoch”) and New Horizon I Holding Company Limited and New Horizon II Holding Company Limited (together, the “New Horizon Shareholders”) will be exchanged for Class C ordinary shares; and shares held by other shareholders will be exchanged for Class A ordinary shares. Fractional entitlements will be aggregated for each shareholder and rounded to the nearest whole share, with one-half rounded upward.

 

After the share exchange, ProLogium will cancel the remaining authorized but unissued pre-recapitalization shares, and the Listing Articles will be adopted and become effective. ProLogium’s authorized share capital will then be $250,000 divided into 2,500,000,000 shares with a par value of $0.0001 each, comprising 1,200,000,000 Class A ordinary shares, 500,000,000 Class B ordinary shares, 700,000,000 Class C ordinary shares and 100,000,000 shares of such class or classes as its board may determine in accordance with the Listing Articles.

 

Available Cash

 

The Amendment defines “Available Cash” as the sum, immediately before closing, of (i) the cash available to be released from TDAC’s trust account after giving effect to all payments resulting from redemptions of TDAC shares and (ii) the net cash proceeds of the PIPE investment actually received by TDAC under the subscription agreements on or before closing and available to TDAC immediately before closing.

 

2

 

 

ProLogium Founder Warrants

 

The Amendment clarifies that “Company Founder Warrants” includes outstanding and unexercised warrants originally issued to a Founder Party under the Series C Preferred Shares Purchase Agreement dated November 8, 2016, including transferred portions and replacement or substitute warrants. Upon the recapitalization, these warrants will become exercisable for Class B ordinary shares if held by a Founder Party immediately before the recapitalization, or Class A ordinary shares if held by another person. The number of underlying shares will be multiplied by the Consolidation Factor and the per-share exercise price will be divided by the Consolidation Factor. Any such warrant or portion held by, or transferred to, a person other than a Founder Party at any time on or after the recapitalization, including after closing, will thereafter be exercisable solely for Class A ordinary shares.

 

Post-Closing Board and Listing Articles

 

The Amendment provides for a nine-member post-closing board divided as nearly equally as possible into three classes. TDAC and TDAC Partners LLC, TDAC’s sponsor (the “Sponsor”), will designate one Class I director, expected to be Michael B. Hoffman. ProLogium’s founder, Yang Szu-Nan (the “Founder”), will designate three directors, including himself, with one serving in Class II and two in Class III. The SBCVC Shareholder and New Epoch will each have the right to appoint one Class I director in accordance with the Listing Articles. Solely to constitute the board at closing, New Horizon I Holding Company Limited will have the right to recommend one additional candidate to serve as an independent director. At least three members of the post-closing board must qualify as independent directors under the applicable rules of the U.S. Securities and Exchange Commission (the “SEC”), subject to exemptions available to foreign private issuers. The initial terms of the three classes will expire at the first, second and third annual general meetings following closing, respectively.

 

The Amendment replaces the form of Listing Articles in its entirety with the form attached as Annex A. Among other provisions, the revised Listing Articles provide for one vote per Class A ordinary share, twelve votes per Class B ordinary share and two votes per Class C ordinary share, with the three classes generally voting together. Class B and Class C ordinary shares are convertible into Class A ordinary shares on a one-for-one basis at the holder’s election and are subject to automatic conversion upon specified transfers and, for Class C ordinary shares, specified ownership-reduction transactions and disqualifying events, in each case subject to the terms and exceptions in the Listing Articles.

 

The Listing Articles also provide continuing director appointment, removal and replacement rights for the Founder, the SBCVC Shareholder, New Epoch and the Sponsor. The SBCVC Shareholder’s right is subject to maintaining ownership of at least 7% of ProLogium’s outstanding shares, and New Epoch’s right is subject to maintaining ownership of at least 42% of the number of Class C ordinary shares it held at closing, in each case with no applicable disqualifying event. The Sponsor’s right to appoint one Class I director terminates permanently when the Sponsor and its affiliates first cease collectively to beneficially own at least 50% of the shares they beneficially owned immediately following closing, counting only issued and outstanding shares and subject to the adjustments specified in the Listing Articles.

 

Dispute Resolution and Other Amendments

 

The Amendment replaces the reference to the Hong Kong International Arbitration Centre with the Singapore International Arbitration Centre and provides, subject to Section 12.16 of the Business Combination Agreement, for disputes relating to the agreement or the contemplated transactions to be resolved by arbitration administered by the Singapore International Arbitration Centre under its applicable rules. The seat of arbitration will be Singapore, the tribunal will consist of three arbitrators and the proceedings will be conducted in English.

 

The Amendment also makes certain administrative and conforming changes and corrects specified internal cross-references. Except as expressly amended, the Business Combination Agreement remains unchanged and in full force and effect.

 

The foregoing description of the Amendment and the transactions contemplated thereby does not purport to be complete and is qualified in its entirety by reference to the Amendment, including its annexes, a copy of which is filed as Exhibit 2.1 to this Current Report on Form 8-K (this “Current Report”) and is incorporated herein by reference.

 

3

 

 

The Amendment is included to provide investors with information regarding its terms and is not intended to provide factual information about TDAC, ProLogium or the other parties beyond the terms of the Amendment. The representations, warranties and covenants in the Business Combination Agreement, as amended, were made solely for purposes of that agreement, as of specified dates and for the benefit of the parties thereto, and may be subject to contractual standards of materiality and qualifications that differ from those applicable to investors. Investors should not rely on those provisions as characterizations of the actual state of facts or condition of any party.

 

Forward-Looking Statements

 

This Current Report contains forward-looking statements, including statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are based on beliefs and assumptions and on information currently available to ProLogium and TDAC. Forward-looking statements include statements regarding the anticipated timing and consummation of the Business Combination, the recapitalization of ProLogium, the issuance and treatment of shares and warrants, the availability of cash and financing at closing, and ProLogium’s post-closing capital structure, governance and board composition. In some cases, forward-looking statements may be identified by words such as “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” “target,” “seek” or similar expressions, although not all forward-looking statements contain these words.

 

TDAC is a blank check company. Accordingly, the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995 is not available to statements made in connection with the Business Combination.

 

These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by the forward-looking statements, including the occurrence of any event, change or other circumstance that could delay, impede or prevent the Business Combination or give rise to the termination of the Business Combination Agreement; the inability to complete the Business Combination due to the failure to obtain shareholder approvals or satisfy other closing conditions; the amount of redemption requests made by TDAC’s public shareholders; the availability of financing and the ability to satisfy the minimum available cash condition under the Business Combination Agreement; the ability to maintain applicable stock exchange listing standards; costs related to the Business Combination; changes in applicable laws or regulations; and the risks and uncertainties described in the registration statement on Form F-4 filed by ProLogium with the SEC and in TDAC’s other filings with the SEC. Forward-looking statements speak only as of the date they are made. Except as required by applicable law, neither ProLogium nor TDAC undertakes any duty to update or revise any forward-looking statement after the date of this Current Report.

 

Additional Information and Where to Find It

 

In connection with the Business Combination, ProLogium has filed with the SEC a registration statement on Form F-4, which includes a preliminary proxy statement of TDAC and a prospectus of ProLogium. The registration statement has not yet been declared effective. After the registration statement is declared effective, the definitive proxy statement/prospectus will be mailed to shareholders of TDAC as of the close of business on November 13, 2026 for voting on the Business Combination. Before making any voting or investment decision, investors and shareholders of TDAC are urged to carefully read the entire registration statement and proxy statement/prospectus, and any other relevant documents filed with the SEC, as well as any amendments or supplements to these documents, because they will contain important information about the Business Combination. The documents filed by TDAC and ProLogium with the SEC may be obtained free of charge at the SEC’s website at www.sec.gov.

 

Participants in the Solicitation

 

ProLogium, TDAC and their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from TDAC shareholders with respect to the Business Combination. Information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of TDAC shareholders in connection with the Business Combination, including a description of their direct or indirect interests, by security holdings or otherwise, is set forth in the registration statement on Form F-4 and will be included in any amendments or supplements thereto.

 

4

 

 

No Offer or Solicitation

 

This Current Report is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of the Business Combination and does not constitute an offer to sell or the solicitation of an offer to buy any securities of ProLogium or TDAC, nor shall there be any sale of any such securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act, or an exemption therefrom.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

The following exhibits are being filed herewith:

 

Exhibit No. Description of Exhibits
2.1 First Amendment to Agreement and Plan of Merger, dated as of November 16, 2026, by and among Translational Development Acquisition Corp., Prologium Holding Inc., PLG Merger Sub 1 and PLG Merger Sub 2.
104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

5

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: November 20, 2026 TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.
     
  By: /s/ Michael B. Hoffman
  Name: Michael B. Hoffman
  Title: Chief Executive Officer

 

6